John Libbey Eurotext

European Journal of Dermatology

Prevention of non-melanoma skin cancers with nicotinamide in transplant recipients: a case-control study Volume 27, issue 4, July-August 2017

Figures

  • Figure 1

Tables

Authors
Department of Dermatology,
IRCCS AOU San Martino IST,
Largo R. Benzi,
10, 16132 Genoa,
Italy
* Reprints
a Authors contributed equally
  • Key words: non-melanoma skin cancer, squamous-cell carcinoma, nicotinamide, transplant recipients, actinic keratosis
  • DOI : 10.1684/ejd.2017.3025
  • Page(s) : 382-5
  • Published in: 2017

Background

Nicotinamide is the precursor of nicotinamide adenine dinucleotide (NAD+), an essential cofactor for adenosine triphosphate (ATP) production. It has recently been reported to be effective in reducing the rates of new non-melanoma skin cancers (NMSCs) and actinic keratosis (AKs).